Northwestern Mutual Wealth Management’s TherapeuticsMD TXMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2
Closed -$2 3946
2024
Q4
$2 Buy
+2
New +$3 ﹤0.01% 3577
2023
Q2
Sell
-140
Closed -$525 3616
2023
Q1
$525 Sell
140
-1
-0.7% -$5 ﹤0.01% 3101
2022
Q4
$788 Hold
141
﹤0.01% 3075
2022
Q3
$1K Hold
141
﹤0.01% 3025
2022
Q2
$1K Buy
141
+1
+0.7% +$10 ﹤0.01% 3087
2022
Q1
$3K Hold
140
﹤0.01% 2874
2021
Q4
$2K Hold
140
﹤0.01% 2965
2021
Q3
$5K Hold
140
﹤0.01% 2686
2021
Q2
$8K Hold
140
﹤0.01% 2519
2021
Q1
$9K Hold
140
﹤0.01% 2319
2020
Q4
$8K Sell
140
-26
-16% -$1.77K ﹤0.01% 2273
2020
Q3
$13K Hold
166
﹤0.01% 1922
2020
Q2
$10K Hold
166
﹤0.01% 1906
2020
Q1
$9K Buy
166
+150
+938% +$14.9K ﹤0.01% 1926
2019
Q4
$2K Hold
16
﹤0.01% 2251
2019
Q3
$3K Sell
16
-180
-92% -$25.4K ﹤0.01% 2219
2019
Q2
$25K Buy
196
+136
+227% +$24.4K ﹤0.01% 1645
2019
Q1
$15K Buy
+60
New +$15.9K ﹤0.01% 1830
2018
Q4
Sell
-60
Closed -$20K 2659
2018
Q3
$20K Hold
60
﹤0.01% 1666
2018
Q2
$19K Buy
+60
New +$18.3K ﹤0.01% 1625

Other funds holding TXMD

Northwestern Mutual Wealth Management's TXMD Position: Q1 2025 in Review

Northwestern Mutual Wealth Management sold out of TherapeuticsMD (TXMD) in Q1 2025, closing a stake of 2 shares — an estimated $2 sold.

Northwestern Mutual Wealth Management first reported a position in TXMD in Q2 2018 and held it in 20 quarters. The position peaked at $25K in Q2 2019. 42 funds tracked by Wall St. Rank hold TXMD as of Q1 2025.

  • Northwestern Mutual Wealth Management reported no remaining TherapeuticsMD position as of Q1 2025 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 2 TherapeuticsMD shares in Q1 2025, an estimated $2.
  • Northwestern Mutual Wealth Management first reported a position in TherapeuticsMD in Q2 2018 and held it in 20 quarters.
  • Northwestern Mutual Wealth Management's TherapeuticsMD position peaked at $25K in Q2 2019.
  • 42 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2025, filed 14 May 2025.